Literature DB >> 15943941

Prevalence and correlates of cocaine physical dependence subtypes using the DSM-IV in outpatients receiving opioid agonist medication.

Elizabeth R Disney1, Michael Kidorf, Van L King, Karin Neufeld, Ken Kolodner, Robert K Brooner.   

Abstract

The present study used a cross-sectional design to examine the relationship between endorsement of physiological dependence to cocaine (i.e., tolerance and/or withdrawal) and lifetime, and current problem severity (i.e., psychiatric and substance use disorders, medical and psychosocial problems) for opioid and cocaine dependent individuals (n=719) newly admitted to a treatment program using opioid-agonist medication. All participants completed the structured clinical interview for the Diagnostic and Statistical Manual (DSM-IV) (SCID-IV) and the Addiction Severity Index (ASI). Participants were first classified into physiological (n=549) versus non-physiological (n=170) cocaine dependence groups for one set of analyses and then categorized into one of four groups for further analyses: (1) tolerance only (n=215), (2) tolerance plus withdrawal (n=279), (3) withdrawal only (n=55) or (4) no physiological dependence (n=170). Those participants who endorsed physiological dependence reported higher rates of lifetime psychiatric and substance use disorders, higher rates of current drug use and more current problems. The four-group analyses showed that endorsement of withdrawal, with or without tolerance, was associated with the most severe problems. These findings suggest that physiological dependence to cocaine (particularly the presence of withdrawal) is a marker for a more severe substance use disorder and higher rates of comorbid psychopathology and other problems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943941     DOI: 10.1016/j.drugalcdep.2004.11.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  5 in total

1.  An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; Robert K Brooner; George E Woody; Ashwin A Patkar; Jack D Blaine
Journal:  J Stud Alcohol Drugs       Date:  2009-05       Impact factor: 2.582

2.  Substance use and response to psychiatric treatment in methadone-treated outpatients with comorbid psychiatric disorder.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Neeraj Gandotra; Sharon Ghazarian; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2014-11-05

3.  Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.

Authors:  Alison Oliveto; James Poling; Michael J Mancino; Zachary Feldman; Joseph F Cubells; Rhonda Pruzinsky; Kishorchandra Gonsai; Christopher Cargile; Mehmet Sofuoglu; Mohit P Chopra; Gerardo Gonzalez-Haddad; Kathleen M Carroll; Thomas R Kosten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

4.  The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Robert K Brooner; Maxine L Stitzer; Ashwin A Patkar; Jack D Blaine
Journal:  Drug Alcohol Depend       Date:  2009-05-06       Impact factor: 4.492

5.  Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.

Authors:  Li-Tzy Wu; Dan G Blazer; Ashwin A Patkar; Maxine L Stitzer; Paul G Wakim; Robert K Brooner
Journal:  Am J Addict       Date:  2009 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.